Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 Hazard ratios for the covariates on intensities

From: Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa

(i, j) VLBL DTB TBB4 Gender React CD4BL WSBL Age
(1, 2) 0.69 2.29 0.31 2.04 4.72 1.17 0.55 1.45
(1, 6) 1.57 0.87 1.11 1.55 0.60 1.30 1.11 0.83
(1, 7) 1.01 0.96 1.00 1.26 0.68 0.92 0.56 0.40
(2, 1) 0.48 1.14 0.76 1.33 1.46 1.17 0.74 2.63
(2, 3) 0.92 1.98 0.67 6.46 0.67 1.37 0.26 0.40
(2, 6) 1.12 0.96 1.69 1.45 0.54 0.997 1.16 1.10
(2, 7) 1.30 1.19 1.92 0.93 0.73 1.33 0.79 0.70
(3, 2) 0.68 1.58 1.10 2.35 2.08 0.69 0.75 0.83
(3, 4) 0.42 2.55 0.53 1.04 0.55 1.57 1.06 0.89
(3, 6) 0.92 1.17 2.03 1.20 0.59 1.05 1.32 1.77
(3, 7) 1.34 0.86 2.34 0.72 0.20 1.20 0.54 2.06
(4, 3) 1.52 1.72 0.86 0.61 1.02 0.27 0.84 1.08
(4, 5) 0.74 2.25 1.65 1.36 0.65 1.05 0.46 0.89
(4, 6) 1.31 1.09 1.09 1.59 0.22 1.01 1.40 1.96
(4, 7) 1.56 1.17 1.88 0.58 0.36 1.02 0.52 2.18
(5, 4) 0.51 1.86 1.02 0.81 1.32 0.61 0.40 0.63
(5, 6) 0.92 0.65 0.41 2.10 0.06 1.003 2.09 2.60
(5, 7) 0.97 1.20 0.88 1.19 0.66 0.87 0.40 2.31